|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income including noncontrolling interests | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation and amortization | |||||
| Amortization of debt issue costs | |||||
| Loss (gain) on disposal of property and equipment | |||||
| Provision for doubtful accounts | |||||
| Deferred taxes | |||||
| Foreign currency transaction gains and losses | |||||
| Equity in losses (earnings) of unconsolidated joint ventures | |||||
| Return on investments in unconsolidated joint ventures | |||||
| Stock-based compensation | |||||
| Contributions of treasury stock | |||||
| Changes in assets and liabilities, net of acquisitions and newly consolidated joint ventures | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Contract liabilities | |||||
| Income taxes | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Proceeds from sale of property and equipment | |||||
| Payments for acquisitions, net of cash acquired | |||||
| Investments in unconsolidated joint ventures | |||||
| Return of investments in unconsolidated joint ventures | |||||
| Proceeds from sales of investments in unconsolidated joint ventures | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from borrowings under credit agreement | |||||
| Repayments of borrowings under credit agreement | |||||
| Repayment of private placement debt | |||||
| Payments for acquired warrants | |||||
| Proceeds from issuance of convertible notes due 2029 | |||||
| Repurchases of convertible notes due 2025 | |||||
| Proceeds from term loan | |||||
| Repayment of delayed draw term loan | |||||
| Payments for debt issuance costs | |||||
| Contributions by noncontrolling interests | |||||
| Distributions to noncontrolling interests | |||||
| Repurchases of common stock | |||||
| Taxes paid on vested stock | |||||
| Capped call transactions | |||||
| Bond hedge termination | |||||
| Redemption of warrants | |||||
| Proceeds from issuance of common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash | |||||
| Beginning of year | |||||
| End of year | |||||
| Cash paid during the year for | |||||
| Interest | |||||
| Income taxes (net of refunds) | |||||
Loading...